Kimball Electronics, Inc. filings document regulatory disclosures for an Indiana-incorporated public manufacturer listed on Nasdaq under KE. Recent 8-K reports furnish quarterly earnings releases and other company events, including operating results, financial-condition commentary, sustainability reporting, manufacturing-capacity announcements, and governance-related updates.
The company’s proxy and annual meeting filings cover board elections, auditor ratification, advisory voting matters, executive compensation disclosures, and share-owner voting results. Together, these filings describe Kimball Electronics’ formal reporting record for its EMS and CMO manufacturing business, governance structure, public-company controls, capital structure, and recurring risk and compliance disclosures.
Kimball Electronics, Inc. (KE) reports that 46,839 common shares were transferred as a bona fide gift to Phillips 2026 Spousal Trust on November 13, 2026. The trust held 129,027 shares afterward. Richard D. Phillips, the CEO and Director who reported the transfer, has no voting or dispositive power over the trust-held securities and disclaims beneficial ownership except to the extent of any pecuniary interest for Section 16. His direct common-stock position after the transfer was zero.
Phillips also held 109,557 directly held restricted shares. The shares include installments of 19,402 scheduled to vest in August 2027, August 2028, and August 2029, and expire if his employment ends for a reason other than death, disability, or retirement.
Kimball Electronics, Inc. (KE) reported first-quarter fiscal 2027 net sales of $390.8 million, up 7% from $365.6 million, while net income fell 74% to $2.6 million and diluted earnings per share was $0.11 versus $0.40. Operating income declined 14% to $12.4 million. Gross profit was $30.9 million, or 7.9% of sales, matching the prior-year margin. Medical sales rose 14% to $115.7 million, and open orders were $690 million, up 16% year over year.
The company completed its Helvoet acquisition on July 1, 2026, recording a net adjusted purchase price of $103.3 million and cash paid, net of cash acquired, of $101.0 million. Helvoet contributed $12.4 million in revenue and a $0.3 million net loss in the quarter. Net cash used in operating activities was $19.3 million, versus $8.1 million provided a year earlier, as operating-asset and liability changes used $34.5 million, largely due to inventory.
At September 30, 2026, borrowings under credit facilities were $235.7 million, and the company was in compliance with its financial covenants. It expects $1.0 million to $2.5 million of additional restructuring costs through fiscal 2027 as the final phase of its plan.
Kimball Electronics, Inc. (KE) reported first-quarter fiscal 2027 net sales of $390.803 million for the three months ended September 30, 2026, up 7% from $365.603 million a year earlier. Medical sales rose 14% to $115.7 million; industrial sales rose 5% to $104.6 million, and automotive sales rose 4% to $170.5 million. GAAP operating income was $12.374 million versus $14.454 million, while net income was $2.642 million versus $10.086 million; diluted EPS was $0.11 versus $0.40.
Operating cash flow was $(19.324) million, compared with $8.065 million a year earlier. Adjusted operating income was $16.990 million and adjusted net income was $6.121 million, versus $17.534 million and $12.250 million, respectively. The company reiterated fiscal 2027 guidance, expecting net sales at the high end of $1,535-$1,560 million, adjusted operating income of 4.4%-4.7% of net sales, and capital expenditures of $50-$60 million.
Kimball Electronics, Inc. shares were reported as beneficially owned by Vanguard Capital Management at 1,175,760 shares, or 4.9% of the class, as of September 30, 2026. Vanguard reported sole voting power over 158,245 shares and sole dispositive power over 1,175,760 shares; shared voting and dispositive power were each zero.
The reported ownership includes securities beneficially owned or deemed beneficially owned by Vanguard Capital Management LLC and specified affiliates and business divisions, including certain Vanguard fund holdings and client securities over which those businesses exercise voting or dispositive power.
Kimball Electronics, Inc. is asking shareholders to vote on four proposals at its November 13, 2026 annual meeting: elect three directors to three-year terms, ratify Deloitte & Touche LLP as auditor for fiscal 2027, hold an advisory vote on named executive officer compensation, and approve an amendment to change the company’s name to Kimball Solutions, Inc. The Board recommends voting FOR each proposal. Shareholders of record as of September 14, 2026 are eligible to vote, with one vote per common share.
For fiscal 2026, Kimball reported $1.4 billion in revenue, a 4.6% adjusted operating income margin, $72 million generated from operating activities, and $117 million in borrowings, which the company described as its lowest debt level in more than four years. It repurchased 447,000 shares for $12 million. The company acquired Helvoet Polymer Technologies on July 1, 2026; Helvoet’s molding capabilities serve medical applications, and approximately 70% of its revenue serves medical end markets. Kimball also opened a 308,000-square-foot medical manufacturing facility in Indianapolis, and management’s outlook projected a return to top-line growth in fiscal 2027.
Kimball Electronics, Inc. (KE) is asking share owners at its November 13, 2026 annual meeting to elect three Class III directors, ratify Deloitte & Touche LLP as independent auditor for fiscal 2027, approve an advisory vote on executive compensation, and amend its Articles of Incorporation to change its name to Kimball Solutions, Inc.
The company reports fiscal 2026 revenue of $1.4 billion, an adjusted operating income margin of 4.6% of net sales, operating cash flow of $72 million, and borrowings of $117 million, its lowest debt level in more than four years. It returned $12 million to share owners through repurchasing 447,000 shares. Kimball completed the acquisition of Helvoet Polymer Technologies, a medical-focused contract development and manufacturing organization with operations in the Netherlands and India, to advance its medical strategy and leverage its new Indianapolis medical facility. The Board highlights a majority-independent, classified structure with an independent chair, three fully independent committees, a strong ESG and human capital focus, and extensive sustainability and governance practices, including detailed risk oversight and global human capital management programs.
Kimball Electronics, Inc. (KE) reported that Chief Operating Officer Steven T. Korn made bona fide gifts of 5,000 shares of common stock on September 3, 2026, to charitable and educational organizations. He continues to hold 60,627 Restricted Shares that vest between August 2027 and August 2029, plus 17,148 shares held indirectly through a retirement fund.
Kimball Electronics, Inc. (KE) reported multiple equity compensation events for Chief Operating Officer Steven T. Korn on August 24, 2026. Prior-year 25,153 Restricted Shares vested and were converted into an equal number of common shares, and 20,065 performance based shares vested into common stock under the 2023 Equity Incentive Plan. Korn also received a new grant of 23,679 Restricted Shares that vest annually from August 2027 to August 2029. To cover tax obligations, 19,660 common shares were withheld at $22.725 per share. An indirect holding of 17,148 common shares is reported in a Retirement Fund after these transactions.
For Kimball Electronics, Inc. (KE), officer Douglas Hass reported compensation-related equity activity on August 24, 2026. Previously granted 12,132 Restricted Shares vested and were converted into an equal number of common shares, while 6,751 common shares were withheld to satisfy tax obligations. Hass also received a new grant of 13,831 Restricted Shares that will vest in tranches in August 2027, 2028, and 2029, plus 3,422 performance based common shares that vested upon certification of performance criteria.